Skip to Content

GGD6 (Azithromycin monohydrate 250 mg)

Pill imprint GGD6 has been identified as Azithromycin monohydrate 250 mg.

Azithromycin is used in the treatment of chlamydia infection; bacterial infection; bronchitis; upper respiratory tract infection; gonococcal infection, uncomplicated (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Azithromycin 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Azithromycin monohydrate 250 mg GGD6
Azithromycin monohydrate 250 mg GGD6  Front
Azithromycin monohydrate 250 mg GGD6  Back
Azithromycin monohydrate 250 mg GGD6
Azithromycin monohydrate
250 mg
15.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
microcrystalline cellulose
soya lecithin
magnesium stearate
polyvinyl alcohol
silicon dioxide
sodium lauryl sulfate
sodium starch glycolate type A potato
corn starch
magnesium silicate
titanium dioxide
xanthan gum
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
58016-4814 Southwood Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.